![](https://www.iabs.org/wp-content/uploads/2021/04/SLIDER-2-scaled.jpg)
![](https://www.iabs.org/wp-content/uploads/2021/05/HV.png)
HUMAN VACCINES
Mission
The Human Vaccines Committee works together to increase global access to critical live attenuated, protein-based, conjugated polysaccharide, and genetically based vaccines by encouraging science-based solutions and supporting access to venues where scientists can meet and discuss challenges and potential opportunities for global alignment.
Goals & Objectives
![](https://www.iabs.org/wp-content/uploads/2021/05/HV_ICONE_1.png)
Enhance the quality and availability of vaccines for personal health, local diseases, and global pandemics.
![](https://www.iabs.org/wp-content/uploads/2021/05/HV_ICONE_2.png)
Provide timely forums for presentation of science and regulatory development of vaccines, as well as new and evolving technologies and development approaches.
![](https://www.iabs.org/wp-content/uploads/2021/05/HV_ICONE_3.png)
Engage global leaders in academia, industry, and regulatory bodies to facilitate standardization of regulatory science principles and practices in vaccines.
![](https://www.iabs.org/wp-content/uploads/2021/05/HV_ICONE_4.png)
Encourage innovation in science and regulation through engagement and collaboration among vaccines experts.
Members
Pieter NEELS
Chair
Steve BLACK
Cincinnati Children’s Hospital
Ananda BANDYOPADHYAY
BMGF
Giuseppe DEL-GIUDICE
GSK
Bernard FRITZELL
Affiliation
Nathalie GARCON
Bioaster
Elwyn GRIFFITHS
IABS
Paul-Henri LAMBERT
University of Geneva
Laurent MALLET
EDQM
Marc VAN OOIJ
J&J
Volker OEPPLING
PEI
Jeff ROBERTS
Merck
Rebecca SHEETS
IABS
Franck VANDENDRIESSCHE
IABS
Priorities & Initiatives
Conferences and Workshop planning
To review IABS Human Vaccines committee and workshops, click on the button below.